{"@id":"https://bioecon.ru/technology/cell-macroencapsulation-for-cns/","@type":"Technology","cluster":"therapeutics-platforms","formats":{"html":"https://cn.bioecon.ru/technology/cell-macroencapsulation-for-cns/","json":"https://cn.bioecon.ru/api/v1/technology/cell-macroencapsulation-for-cns/index.json"},"id":"cell-macroencapsulation-for-cns","industries":["pharma","biomanufacturing"],"lang":"cn","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/lonza-group/","https://bioecon.ru/companies/agc-biologics/","https://bioecon.ru/companies/integriculture/","https://bioecon.ru/companies/orf-genetics/","https://bioecon.ru/companies/simple-planet/","https://bioecon.ru/companies/cellmeat/","https://bioecon.ru/companies/aleph-farms/","https://bioecon.ru/companies/newlimit/","https://bioecon.ru/companies/cryoport-systems/","https://bioecon.ru/companies/becton-dickinson/","https://bioecon.ru/companies/eversyn-gmbh/"]},"maturity":7,"name":"用于穿透血脑屏障的中枢神经植入式活细胞宏观胶囊化系统","regions":["ch","eu","us","cn"],"risk":"high","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"工程化供体细胞株构建"},{"n":2,"title":"免疫隔离半透中空纤维膜制造"},{"n":3,"title":"立体定向微创脑室植入"},{"n":4,"title":"数年期零免疫排斥原位分泌"}],"summary":"植入式半透性中空纤维宏观胶囊装置，内部封装经基因工程改造的治疗性细胞，能够长期在脑脊液中自主持续分泌神经营养因子与抗体，彻底突破血脑屏障。","url":"/technology/cell-macroencapsulation-for-cns/","verified":"2026-11-22"}